Top

Published in:

01-08-2020 | Letter

Angiostatic effects of ascorbic acid: current status and future perspectives

Author: Muhammad Torequl Islam

Published in: Angiogenesis | Issue 3/2020

Abstract

Anti-angiogenesis effect of ascorbic acid (AA) is still controversial. However, most of the scientific evidence suggests that AA has anti-angiogenesis effects on a number of test systems, including laboratory animals, human beings, and their derived cell lines. The information provided in this paper suggests that AA may be a hopeful angiostatic agent for the treatment of cancer.

Shenoy N, Creagan E, Witzig T, Levine M (2018) Ascorbic acid in cancer treatment: let the phoenix fly. Cancer Cell 34(5):700–706. https://doi.org/10.1016/j.ccell.2018.07.014 CrossRefPubMedPubMedCentral

Schoenfeld JD, Sibenaller ZA, Mapuskar KA (2017) O₂^•– and H₂O₂-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell 31(4):487-500.e8. https://doi.org/10.1016/j.ccell.2017.02.018 CrossRefPubMedPubMedCentral

Ramjiawan RR, Griffioen AW, Duda DG (2017) Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis 20:185–204CrossRef

Padayatty SJ, Levine M. Vitamin C (2016) physiology: the known and the unknown and Goldilocks. Oral Dis 22:463–493CrossRef

Macan AM, Kraljević TG, Raić-Malić S (2019) Therapeutic perspective of vitamin C and its derivatives. Antioxidants (Basel) 8:247. https://doi.org/10.3390/antiox8080247 CrossRef

Pawlowska E, Szczepanska J, Blasiak J (2019) Pro- and antioxidant effects of vitamin C in cancer in correspondence to its dietary and pharmacological concentrations. Oxid Med Cell Longev 2019:7286737. https://doi.org/10.1155/2019/7286737 CrossRefPubMedPubMedCentral

Telang S, Clem AL, Eaton JW, Chesney J (2007) Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia 9:47–56CrossRef

Mikirova NA, Ichim TE, Riordan NH (2008) Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med 6:50. https://doi.org/10.1186/1479-5876-6-50 CrossRefPubMedPubMedCentral

Mikirova NA, Casciari JJ, Riordan NH (2010) Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res 2:2. https://doi.org/10.1186/2040-2384-2-2 CrossRefPubMedPubMedCentral

10.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells. Oncol Rep 14:1399–1404PubMed

11.

Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis. Oncol Rep 14:807–815PubMed

12.

Peyman GA, Kivilcim M, Morales AM, DellaCroce JT, Conway MD (2007) Inhibition of corneal angiogenesis by ascorbic acid in the rat model. Graefes Arch Clin Exp Ophthalmol 245:1461–1467CrossRef

13.

Mousa AS, Mousa SA (2005) Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr Cancer 53:104–110CrossRef

14.

Ashino H, Shimamura M, Nakajima H et al (2003) Novel function of ascorbic acid as an angiostatic factor. Angiogenesis 6:259–269CrossRef

15.

Orosz KE, Gupta S, Hassink M, Abdel-Rahman M, Moldovan L, Davidorf FH, Moldovan NI (2004) Delivery of antiangiogenic and antioxidant drugs of ophthalmic interest through a nanoporous inorganic filter. Mol Vis 10:555–565PubMed

16.

Castro M, Caprile T, Astuya A et al (2001) High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem 78:815–823CrossRef

17.

Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH (2003) Anti-angiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J Ethnopharmacol 88:113–116CrossRef

18.

Yeom C-H, Lee G, Park J-H et al (2009) High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med 7:70. https://doi.org/10.1186/1479-5876-7-70 CrossRefPubMedPubMedCentral

19.

Duffy AM, Bouchier-Hayes DJ, Harmey JH. Vascular endothelial growth factor (vegf) and its role in non-endothelial cells: autocrine signalling by vegf. madame curie bioscience database. https://www.ncbi.nlm.nih.gov/books/NBK6482/

20.

Ulker E, Parker WH, Raj A, Qu Z-c, May JM (2016) Ascorbic acid prevents VEGF-induced increases in endothelial barrier permeability. Mol Cell Biochem 412:73–79CrossRef

21.

Sant DW, Camarena V, Mustafi S et al (2018) Ascorbate suppresses VEGF expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 59:3608–3618CrossRef

22.

Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 72:139–146CrossRef

23.

Luchtel RA, Bhagat T, Pradhan K, Jacobs WR Jr, Levine M, Verma A, Shenoy N (2020) High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc Natl Acad Sci USA 117(3):1666–1677. https://doi.org/10.1073/pnas.1908158117 CrossRefPubMed

24.

Magrì A, Germano G, Lorenzato A et al (2020) High-dose vitamin C enhances cancer immunotherapy. Sci Transl Med 12(532):eaay8707. https://doi.org/10.1126/scitranslmed.aay8707 CrossRefPubMed

25.

Castelo-Branco PV, Alves HJ, Pontes RL, Maciel-Silva VL, Pereira SRF (2019) Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity. Int J Parasitol Drugs Drug Resist 9:8–15CrossRef

26.

Fowler AA, Syed AA, Knowlson S et al (2014) Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 12:32. https://doi.org/10.1186/1479-5876-12-32 CrossRefPubMedPubMedCentral

27.

van Gorkom GNY, Lookermans EL, Van Elssen Catharina HMJ, Bos GMJ (2019) The effect of vitamin C (ascorbic acid) in the treatment of patients with cancer: a systematic review. Nutrients 11:977. https://doi.org/10.3390/nu11050977 CrossRefPubMedCentral

Title: Angiostatic effects of ascorbic acid: current status and future perspectives
Author: Muhammad Torequl Islam
Publication date: 01-08-2020
Publisher: Springer Netherlands
Published in: Angiogenesis / Issue 3/2020
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-020-09719-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2020

Endothelial deletion of ADAM10, a key regulator of Notch signaling, causes impaired decidualization and reduced fertility in female mice

New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury

Matrix deformations around angiogenic sprouts correlate to sprout dynamics and suggest pulling activity

Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer

Simultaneous fluorescence imaging of distinct nerve and blood vessel patterns in dual Thy1-YFP and Flt1-DsRed transgenic mice

Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials